Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2007-12-25
2007-12-25
Keys, Rosalynd (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C514S717000, C568S662000, C568S644000, C568S807000
Reexamination Certificate
active
11066795
ABSTRACT:
Novel biaromatic vitamin D analogues have the general formula (I):and are suited for a wide variety of pharmaceutical applications, whether in human or veterinary medicine, and also for cosmetic applications.
REFERENCES:
patent: 5877342 (1999-03-01), Bernardon et al.
patent: 6335359 (2002-01-01), Dalko et al.
patent: 6689922 (2004-02-01), Bernardon
patent: 0 776 881 (1997-06-01), None
patent: 0 850 909 (1998-07-01), None
patent: WO 00/26167 (2000-05-01), None
Silverman, Richard B., The Organic Chemistry of Drug Design and Drug Action, 1992, pp. 15-22.
International Search Report Corresponding to PCT/FR 00/03250 Issued May 7, 2001- 2 Pages.
Biadatti Thibaud
Jomard Andre
Thoreau Etienne
Voegel Johannes
Buchanan & Ingersoll & Rooney PC
Galderma Research & Development
Keys Rosalynd
LandOfFree
Vitamin D analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3862642